EUVIMEDEUVIMED entdecken
Crossref

An AI-Guided Biparatopic B7H3-Targeting ADC Demonstrates Enhanced Preclinical Efficacy

Y. Wu, S. Jiang, B. Yang, D. Liu, Y. Shang, J. Tian, Z. Chen, H. Ran, L. Tian, J. Peng, Z. Zhu

European Journal of Cancer · 2026-11 · 248 · 117502

DOI: 10.1016/j.ejca.2026.117502 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von Y. Wu und 10 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Wu, Y., Jiang, S., Yang, B., Liu, D., Shang, Y., Tian, J., Chen, Z., Ran, H., Tian, L., Peng, J., & Zhu, Z. (2026). An AI-Guided Biparatopic B7H3-Targeting ADC Demonstrates Enhanced Preclinical Efficacy. European Journal of Cancer, 248, 117502. https://doi.org/10.1016/j.ejca.2026.117502

Vancouver

Wu Y, Jiang S, Yang B, Liu D, Shang Y, Tian J, et al. An AI-Guided Biparatopic B7H3-Targeting ADC Demonstrates Enhanced Preclinical Efficacy. European Journal of Cancer. 2026;248:117502. doi:10.1016/j.ejca.2026.117502

BibTeX
@article{Wu2026,
  author = {Wu, Y. and Jiang, S. and Yang, B. and Liu, D. and Shang, Y. and Tian, J. and Chen, Z. and Ran, H. and Tian, L. and Peng, J. and Zhu, Z.},
  title = {An AI-Guided Biparatopic B7H3-Targeting ADC Demonstrates Enhanced Preclinical Efficacy},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {248},
  pages = {117502},
  doi = {10.1016/j.ejca.2026.117502}
}
Kostenlos starten →